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ABSTRACT 
Two new tetrahydroanthraquinone derivatives, altersolanol Q (1) and 10-
methylaltersolanol Q (2), and the new dimer alterporriol X (3), together with 13 known 
analogues were isolated from white bean solid culture media of the endophytic fungus, 
Stemphylium globuliferum, obtained from the Egyptian mangrove plant Avicennia marina. 
The present study resulted in the production of a large diversity of secondary metabolites 
including new derivatives. Their structures were elucidated using one- and two-dimensional 
NMR spectroscopy as well as HRESIMS. The absolute configurations of the new compounds 
1–3 were determined by TDDFT-ECD calculations or by comparing ECD data with those of 
known analogues. Compounds 1–3 were tested against the L5178Y mouse lymphoma cell line 
but proved to be inactive in contrast to some of the known compounds such as altersolanol A 
(6) that were likewise isolated in this study. 
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Introduction 
Mangrove-derived endophytic fungi are considered an important source for bioactive 
secondary metabolites that could be of potential use as lead compounds for pharmaceutically 
relevant drugs.1–3 Endophytic fungi that inhabit mangrove plants are thought to promote 
adaptation of their host to survive under harsh ecological conditions such as high salt 
concentration, high temperature, low oxygen concentration due to changing levels of 
submersion in seawater, or to counter biological stress caused by herbivores and microbial 
pathogens.4 This encouraged us to employ the OSMAC (One Strain Many Compounds)5,6 
approach to Stemphylium globuliferum, an endophytic fungus isolated from the mangrove 
plant Avicennia marina (Acanthaceae) collected from Hurghada in Egypt, by changing the 
culture media in order to trigger the stimulation of silent biogenetic gene clusters.3 Most 
compounds previously isolated from this endophyte were reported to be anthraquinone or 
tetrahydroanthraquinone derivatives including homo- and heterodimers, which are known to 
possess a wide range of biological activities. For example, altersolanol A (6), a 
tetrahydroanthraquinone derivative obtained in this study but also isolated from Phomopsis 
juniperovora,7 Dactylaria lutea,8 Alternaria sp.,9 and Stemphylium globuliferum,10 is a potent 
inhibitor of plant respiration, blocking the uptake of essential metabolites required for 
photosynthesis11 and also exhibits cytotoxic activity against 34 human cancer cell lines.12 In 
the present study, two new tetrahydroanthraquinone derivatives, altersolanol Q (1) and 10-
methylaltersolanol Q (2), one new anthranoid dimer alterporriol X (3), as well as 13 known 
analogues (4–16) were isolated (Figure 1). Their structure elucidation including 
determination of the absolute configuration as well as biological activities are reported. 
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Figure 1. Structures of compounds isolated from S. globuliferum. 
Results and Discussion 
Compound 1 showed UV absorbances at λmax 224, 268 and 334 nm, similar to those of 
known altersolanol derivatives.13,14 It exhibited the molecular formula C16H20O6 as established 
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by HRESIMS. The 1H NMR spectrum (Table 1) showed two meta-coupling aromatic protons 
at δH 6.98 (d, H-8) and 6.63 (d, H-6), two oxygenated methines at δH 4.93 (d, H-10) and 3.43 
(dd, H-3), one methoxy group at δH 3.78 (s, H3-12), one singlet methyl group at δH 1.31 (s, 
H3-11), as well as six aliphatic protons at δH 3.05 (td, H-9a), 2.38 (dd, H-1eq), 2.22 (td, H-4ax), 
1.93 (tdd, H-4a), 1.71 (ddd, H-4eq), and 1.33 (dd, H-1ax). The planar structure of 1 was 
elucidated through detailed analysis of 2D NMR spectra (Figure 2). The COSY correlations 
between H2-1/H-9a, H-9a/H-4a, H-4a/H-10, H-4a/H2-4 and H2-4/H-3, together with the 
HMBC correlations from H3-11 to C-1, C-2 and C-3 indicated the presence of a cyclohexane 
ring with a methyl and a hydroxy group attached at C-2, as well as a hydroxy group at C-3. 
The HMBC correlations from H-6 to C-5, C-7, C-8 and C-10a, from H-8 to C-6, C-7, C-8a 
and C-10a, and from H3-12 to C-7 established the presence of a 1,2,3,5-tetrasubstituted 
benzene ring with a hydroxy and  a methoxy group attached at C-5 and C-7, respectively. 
Finally, the HMBC correlations from H2-1, H-8 and H-9a to C-9 supported the linkage from 
C-8a to C-9a via the keto carbonyl moiety C-9, and the HMBC correlations from H-10 to C-5, 
C-8a and C-10a allowed the assignment of the linkage between C-10 and C-10a. 
A literature survey indicated that 1 exhibited the same planar structure as altersolanol J,13 
for which the absolute configuration had only been proposed based on biogenetic 
considerations. However, the small value of J4a,10 (2.7 Hz) in 1 in comparison with that of 
altersolanol J (9.6 Hz) suggested the cis orientation of H-4a and H-10 in 1 rather than trans 
orientation in altersolanol J. The relative configuration of the remaining chiral centres was 
deduced to be the same as that of altersolanol J based on the similar coupling constants and 
ROESY relationships. The absolute configuration of 1 was determined as 2S, 3R, 4aS, 9aS, 
and 10S on the ground of the TDDFT-ECD calculation of the related 10-methyl derivative 2 
(vide infra). 
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Figure 2. Key COSY, HMBC correlations of compound 1. 
Table 1. NMR data of compounds 1 and 2.a 
No. 1   2  
δH (J in Hz) δC, type  δH (J in Hz) δC, type 
1ax 1.33, dd (14.2, 12.2) 39.0, CH2  1.27, dd (14.2, 12.2)  39.3, CH2 
1eq 2.38, dd (14.2, 4.0)   2.37, dd (14.2, 3.9)  
2  72.1, C   72.1, C 
3 3.43, dd (11.8, 4.6) 75.5, CH  3.39, dd (11.8, 4.6) 75.4, CH 
4eq 1.71, ddd (12.2, 4.6, 3.5) 33.8, CH2  1.76, ddd (12.2, 4.6, 3.5) 34.0, CH2 
4ax 2.22, td (12.2, 11.8)   2.23, td (12.2, 11.8)  
4a 1.93, tdd (12.2, 3.5, 2.7) 43.9, CH  1.96, tdd (12.2, 3.5, 2.3) 44.5, CH 
5  158.0, C   158.1, C 
6 6.63, d (2.5) 108.2, CH  6.63, d (2.5) 107.8, CH 
7  161.7, C   161.8, C 
8 6.98, d (2.5) 101.8, CH  7.01, d (2.5) 102.8, CH 
8a  134.2, C   134.6, C 
9  202.2, C   202.2, C 
9a 3.05, td (12.2, 4.0) 40.7, CH  3.05, td (12.2, 3.9) 41.3, CH 
10 4.93, d (2.7) 64.0, CH  4.60, d (2.3) 73.2, CH 
10a  126.0, C   124.4, C 
11 1.31, s 27.3, CH3  1.29, s 27.2, CH3 
12 3.78, s 55.8, CH3  3.78, s 55.8, CH3 
13    3.45, s 58.6, CH3 
aMeasured in MeOH-d4  (1H at 600 MHz and 13C at 150 MHz). 
The molecular formula of 2 was established as C17H22O6 by HRESIMS, indicating an 
increase of 14 amu in comparison with altersolanol Q (1). The UV and NMR spectra of 
compound 2 resembled those of 1 except for the appearance of an additional methoxy group 
(δC 58.6, δH 3.45, CH3-13) in 2. The attachment of this methoxy group at C-10 was confirmed 
by the HMBC correlation from H3-13 to C-10 along with the obvious downfield shift of C-10 
(δC 73.2) in 2 compared to the corresponding carbon (δC 64.0) in 1. Thus, compound 2 was 
determined as 10-methylaltersolanol Q. Its relative configuration was deduced to be the same 
as 1 due to the similarity of their J values and ROESY correlations. 
For the assignment of the absolute configuration of 2, the solution TDDFT-ECD 
approach was pursued for the arbitrarily chosen (2S,3R,4aS,9aS,10S) enantiomer. The initial 
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20 MMFF conformers were reoptimized at B3LYP/6-31G(d) in vacuo and B97D/TZVP 
PCM/MeCN levels yielding 6 and 10 low-energy (≥2%) conformers, respectively. In all the 
computed B3LYP/6-31G(d) conformers, the 10-OMe and 2-OH groups adopted axial 
orientation (Figure 3), while the 3-OH was equatorial and the fused cyclohexenone ring of 
the tetralone chromophore had M-helicity (ω10a,10,4a,9a = −58.0°). The conformers differed only 
in the orientations of the methoxy group and hydroxyl protons. Similarly to coniothyrinone 
D,15 the carbonyl group of 2 could not form an intramolecular hydrogen bond with the 
phenolic hydroxyl group, which resulted in the separation of the n-π* [negative Cotton effect 
(CE) at 350 nm] and π-π* (positive CE at 312 nm) transitions of the tetralone chromophore in 
the experimental ECD spectrum. According to the ECD study of coniothyrinone D,15 the 
negative n-π* CE of 2 derives from M-helicity of the tetralone chromophore implying 
(2S,3R,4aS,9aS,10S) absolute configuration. This assignment was confirmed by ECD 
calculations of the computed conformers of (2S,3R,4aS,9aS,10S)-2 with various functionals 
and TZVP basis set affording good agreement with the experimental ECD spectrum (Figure 
4). Since all the low-energy conformers gave similar ECD spectra, the absolute configuration 
of 2 could be unambiguously determined as (2S,3R,4aS,9aS,10S). 
 
Figure 3. Structure and population of the low-energy B3LYP/6-31G(d) conformers (≥2%) of 
(2S,3R,4aS,9aS,10S)-2. 
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Figure 4. Comparison of the experimental ECD of 2 (black solid) with the Boltzmann-
weighted BH&HLYP/TZVP ECD spectra of (2S,3R,4aS,9aS,10S)-2 (red dashed) computed 
for the 6 B3LYP/6-31G(d) in vacuo conformers. Bars represent the computed rotational 
strength values of the lowest-energy conformer. 
Compound 3 was isolated as orange powder. Its UV spectrum displayed absorption 
bands at λmax 202, 224, 285 and 400 nm, which were similar to those of alterporriol W.16 The 
molecular formula was determined to be C32H26O11 by HRESIMS, missing one oxygen atom 
compared to alterporriol W. The 1H and 13C NMR data of 3 (Table 2) were closely related to 
those of alterporriol W,16 except for the replacement of one oxygenated methine group by a 
methylene group (δC 36.0, δH 2.51 and 2.36, CH2-1'). The HMBC correlations from H3-11' (δH 
1.19, s) to C-2' (δC 70.2), C-3' (δC 71.3) and the methylene CH2-1', and in turn from the 
protons of CH2-1' to C-2', C-3', C-4'a (δC 144.4), C-9'a (δC 141.9), indicated that the additional 
methylene group CH2-1' was located at C-1' in 3. Thus, compound 3 was elucidated as 1'-
dehydroxyalterporriol W, for which the trivial name alterporriol X is proposed. Alterporriol X 
is a hetero dimer consisting of altersolanol B (7) and macrosporin (10) subunits which were 
co-isolated in the present study. This structural assignment was corroborated by interpretation 
of 2D NMR spectra which were in good agreement with those acquired for altersolanol B and 
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macrosporin, respectively. The absolute configurations at C-2' and C-3' in 3 were assumed to 
be the same as in altersolanol B (7) due to their close biogenetic relationship. Due to the 4-8' 
biaryl linkage of the anthraquinone-tetrahydroanthraquione dimer, besides the central chirality 
elements, alterporriol X (3) had also axial chirality, which could be determined as (aR) on the 
basis of its similar ECD spectrum to that of the related biaryl natural product alterporriol W 
having (aR) axial chirality.16 
Table 2. NMR data of compound 3.a 
No. δH (J in Hz) δC, type  No. δH (J in Hz) δC, type 
1 8.14, s 130.2, CH  1' 2.51, d (19.2) 36.0, CH2 
     2.36, d (19.2)  
2  132.0, C   2'  70.2, C 
3  159.2, C   3' 3.72, m 71.3, CH 
4  n. d.b  4' 2.85, m 29.7, CH2 
     2.73, m  
4a  131.5, C  4'a  144.4, C 
5  166.2, C   5'  165.7, C 
6 6.66, d (2.6) 106.1, CH  6' 6.87, s 104.3, C 
7  166.7, C  7'  165.4, C 
8 7.25, d (2.6) 107.0, CH  8'  122.7, C 
8a  135.8, C  8'a  125.9, C 
9  181.8, C  9'  n. d. 
9a  126.0, C  9'a  141.9, C 
10  188.8, C  10'  189.4, C 
10a  111.5, C   10'a  110.4, C 
11 2.41, s 16.9, CH3  11' 1.19, s 25.0, CH3 
12 3.96, s 56.2, CH3  12' 3.77, s 56.8, CH3 
 aMeasured in acetone-d6  (1H at 600 MHz and 13C at 150 MHz).  bn.d. = not detected. 
By comparison of NMR and MS data with the literature, the 13 known compounds were 
identified as dihydroaltersolanol B (4) and C (5),17 altersolanol A (6),18 B (7),19 and N (8),10 1-
hydroxy-3-methoxy-6-methylanthraquinone (9),20 macrosporin (10),21 altechromone A (11),22 
alterporriol D (12),18 E (13),18 R (14),9 V (15),23 and W (16).23 
Dihydroaltersolanol C (5),17 altersolanol A (6),17 B (7),17 N (8),10 and alterporriol E 
(13)17 have been reported to exhibit potent cytotoxicity against L5178Y mouse lymphoma cell 
line with IC50 values in the low micromolar range. However, the new compounds 1–3 showed 
no significant activity when tested at a dose of 10 µg/mL each. 
S. globuliferum is well known for its production of anthraquinone or 
tetrahydroanthraquinone derivatives including various monomers and dimers. In the present 
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study, fermentation of the titled fungus on solid white bean medium yielded macrosporin (10) 
as an anthraquinone monomer, which gave rise to three anthraquinone homodimers 
alterporriol R (14), V (15) and W (16), and altersolanol A (6) as a tetrahydroanthraquinone 
monomer, from which two tetrahydroanthraquinone homodimers alterporriol D (12) and E 
(13) were detected. In addition, the new heterodimer alterporriol X (3) is formed from both 
macrosporin (10) and altersolanol B (7) units. S. globuliferum was previously cultivated on 
solid rice medium and yielded tetrahydroanthraquinones, anthraquinones, and 
tetrahydroanthraquinone dimers.10,17 However, in this study the fermentation of S. 
globuliferum on white beans afforded three new compounds (1-3), in addition to some 
metabolites which were not isolated from the rice culture, including one anthraquinone (9), 
one chromone derivative (11), and three anthraquinone dimers (14–16), thereby providing 
evidence for the power of the OSMAC approach. 
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Highlights 
 
 Two new tetrahydroanthraquinone derivatives and one new dimer were isolated. 
 TDDFT-ECD calculations were performed to determine the absolute configuration. 
 OSMAC approach was employed by using white bean medium instead of rice medium. 
 
 
